Metropolitan Life Insurance Company (MetLife)’s Kezar Life Sciences KZR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-290	Closed	-$7.11K	–	2423
2023 Q2	$7.11K	Hold	290	–	–	﹤0.01%	2426
2023 Q1	$9.09K	Sell	290 -29	-9%	-$1.68K	﹤0.01%	2192
2022 Q4	$22.4K	Hold	319	–	–	﹤0.01%	1953
2022 Q3	$27.4K	Buy	319 +78	+32%	+$7.58K	﹤0.01%	1844
2022 Q2	$20K	Hold	241	–	–	﹤0.01%	2055
2022 Q1	$40.1K	Sell	241 -721	-75%	-$103K	﹤0.01%	1720
2021 Q4	$161K	Sell	962 -17	-2%	-$1.92K	﹤0.01%	2171
2021 Q3	$84.6K	Buy	+979	New	+$64.8K	﹤0.01%	2618
2019 Q3	–	Sell	-502	Closed	-$38.7K	–	2599
2019 Q2	$38.7K	Hold	502	–	–	﹤0.01%	2523
2019 Q1	$89.1K	Buy	+502	New	+$98.9K	﹤0.01%	2384

Other funds holding KZR

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s KZR Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Kezar Life Sciences (KZR) in Q3 2023, closing a stake of 290 shares — an estimated $7.11K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in KZR in Q1 2019 and held it in 10 quarters. The position peaked at $161K in Q4 2021. 82 funds tracked by Wall St. Rank hold KZR as of Q3 2023.

Metropolitan Life Insurance Company (MetLife) reported no remaining Kezar Life Sciences position as of Q3 2023 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 290 Kezar Life Sciences shares in Q3 2023, an estimated $7.11K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Kezar Life Sciences in Q1 2019 and held it in 10 quarters.
Metropolitan Life Insurance Company (MetLife)'s Kezar Life Sciences position peaked at $161K in Q4 2021.
82 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.